Taiwan's next biotech prescription: AI drug discovery, smart devices and biomedical chips
DIGITIMESen

Taiwan is charting a new direction for its biomedical industry, drawing on its strengths in semiconductors, AI hardware, precision manufacturing and healthcare. AI-powered drug discovery, smart medical devices and biomedical chips are emerging as priority areas.
This is a short summary published by AI Global Wire. The full article is owned and hosted by DIGITIMES — open it there to read it in full.
Read the full story at DIGITIMESRelated AI news
- 調查:法國 2027 總統大選,3% 選民可能依 AI 建議投票TechNews (TW) · August 28, 2026
- 輝達市值單日暴增 4,420 億美元!創史上第二大單日漲幅TechNews (TW) · August 28, 2026
- Salesforce 財報打臉「SaaS 已死」論 股價爆噴 22%TechNews (TW) · August 28, 2026
- Nvidia adds $442b in market value on AI growth outlookTech in Asia · August 28, 2026
- Marvell 客製晶片明年營收翻倍、財測升 盤後卻崩TechNews (TW) · August 28, 2026
- Marvell’s stock sinks despite earnings beat and strong guidanceSiliconANGLE · August 28, 2026